Hepatitis B virus in Lao dentists: A cross-sectional serological study.


Journal

Annals of hepatology
ISSN: 1665-2681
Titre abrégé: Ann Hepatol
Pays: Mexico
ID NLM: 101155885

Informations de publication

Date de publication:
Historique:
received: 03 09 2020
revised: 20 10 2020
accepted: 21 10 2020
pubmed: 21 11 2020
medline: 15 12 2021
entrez: 20 11 2020
Statut: ppublish

Résumé

Hepatitis B virus (HBV) is endemic in Lao PDR, with up to 10% chronic infections in adults. Dentists have high risk of exposure and transmission to their patients. The aim was to investigate the serological profiles of vaccination, exposure and susceptibility to HBV. In addition, we determined the knowledge, attitude and practice (KAP) of Lao dentists toward HBV. Dentists and dental assistants were recruited from 186 private dental clinics in Vientiane Capital. They completed a KAP questionnaire and serum was tested by ELISA for HBV markers (anti-HB surface antigen, anti-core antigen, HBV surface antigen). 206 dentists and 111 dental workers aged between 18-63 years were included. Serology data showed that 37.8% had previous exposure (49.0% of males and 32.4% of females) and 5.0% were chronically infected (7.7% of males and 3.8% of females). Less than 15% had serological evidence of vaccination and 66.8% were unprotected against infection. Knowledge of HBV was mostly low, for example 61.8% were aware of the childhood HBV vaccine. Just over half said that they should give dental care to HBV carriers. About one quarter reported accidental blood exposure during the last 6 months but knowledge about procedures after exposure was low. Lao dentists are at high risk of occupational exposure to HBV but have low awareness and serological protection. There is a need to introduce mandatory vaccination, to strengthen occupational health in health care providers and to further develop the academic curricula of dental students.

Identifiants

pubmed: 33217587
pii: S1665-2681(20)30207-6
doi: 10.1016/j.aohep.2020.10.010
pii:
doi:

Substances chimiques

Hepatitis B Antibodies 0
Hepatitis B Surface Antigens 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100282

Informations de copyright

Copyright © 2020 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

Bouasone Mangkara (B)

Lao Tropical and Public Health Institute, Ministry of Health, Vientiane, Lao People's Democratic Republic.

Kinnaly Xaydalasouk (K)

Institut Pasteur du Laos, Vientiane, Lao People's Democratic Republic.

Phetsavanh Chanthavilay (P)

Institute of Research and Education Development, University of Health Sciences, Vientiane, Lao People's Democratic Republic.

Sengchanh Kounnavong (S)

Lao Tropical and Public Health Institute, Ministry of Health, Vientiane, Lao People's Democratic Republic.

Somphou Sayasone (S)

Lao Tropical and Public Health Institute, Ministry of Health, Vientiane, Lao People's Democratic Republic.

Claude P Muller (CP)

Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.

Phimpha Paboriboune (P)

Center of Infectiology Lao-Christophe Mérieux, Lao People's Democratic Republic.

Antony P Black (AP)

Institut Pasteur du Laos, Vientiane, Lao People's Democratic Republic. Electronic address: a.black@pasteur.la.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH